PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | +2.7% | 24,944 | +4.1% | 0.00% | – |
| Q2 2023 | $150 | +32.7% | 23,961 | +1.5% | 0.00% | – |
| Q1 2023 | $113 | -29.4% | 23,617 | +28.8% | 0.00% | – |
| Q4 2022 | $160 | -99.9% | 18,339 | +2.7% | 0.00% | – |
| Q3 2022 | $213,000 | -4.1% | 17,864 | +14.4% | 0.00% | – |
| Q2 2022 | $222,000 | -26.5% | 15,613 | +7.6% | 0.00% | – |
| Q1 2022 | $302,000 | -74.5% | 14,504 | -71.7% | 0.00% | – |
| Q4 2021 | $1,183,000 | -73.8% | 51,224 | -66.3% | 0.00% | – |
| Q3 2021 | $4,523,000 | +15.2% | 151,778 | +27.1% | 0.00% | – |
| Q1 2021 | $3,926,000 | – | 119,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |